2nd TCE for Autoimmune Disease Summit

Certara is proud to support the 2nd T-Cell Engager for Autoimmune Disease Summit, where discovery, translational, preclinical, and clinical leaders are tackling the field’s biggest challenges: reducing CRS toxicities, improving tissue-selective immune depletion, and expanding T-cell engager (TCE) targets beyond B-cells. As autoimmune TCEs move from oncology-inspired concepts into one of the industry’s most closely watched therapeutic modalities, Certara’s quantitative systems pharmacology (QSP) expertise offers a mechanistic path through the dosing and translational questions shaping this fast-moving field.